Dedicated to the discovery, development, and commercialization of novel targeted therapies to treat cancer
Anchiano Therapeutics is a dynamic biopharmaceutical company focused on the discovery, development, and commercialization of innovative targeted therapies for cancer treatment. Anchiano Therapeutics is committed to advancing medical science through cutting-edge research and development, striving to create impactful solutions in the fight against cancer.
Located at One Kendall Square, BLDG 1400E, STE 14-105, Cambridge, MA 02139, US, Anchiano Therapeutics operates with a dedication to pioneering novel approaches in targeted therapies. The company's focus includes a range of advanced techniques such as gene therapy, immunotherapy and oncology.
Anchiano Therapeutics is dedicated to improving patient outcomes through its commitment to innovation and excellence in biotechnology research. Anchiano Therapeutics invites you to learn more about its mission and contribute to the future of cancer treatment.
We invite the management team at Anchiano Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight your achievements and innovations.
Anchiano Therapeutics est une société biopharmaceutique dynamique axée sur la découverte, le développement et la commercialisation de thérapies ciblées innovantes pour le traitement du cancer. Anchiano Therapeutics s'engage à faire progresser la science médicale grâce à la recherche et au développement de pointe, en s'efforçant de créer des solutions percutantes dans la lutte contre le cancer.
Situé à One Kendall Square, BLDG 1400E, STE 14-105, Cambridge, MA 02139, US, Anchiano Therapeutics opère avec un engagement à lancer de nouvelles approches dans les thérapies ciblées. L'objectif de l'entreprise comprend une gamme de techniques avancées telles que la thérapie génique, l'immunothérapie et l'oncologie.
Anchiano Therapeutics se consacre à l'amélioration des résultats pour les patients grâce à son engagement envers l'innovation et l'excellence dans la recherche biotechnologique. Anchiano Therapeutics vous invite à en savoir plus sur sa mission et à contribuer à l'avenir du traitement du cancer.
Nous invitons l'équipe de direction d'Anchiano Therapeutics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en valeur vos réalisations et vos innovations.
Compare Anchiano Therapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
Anchiano TherapeuticsMain Company |
IMV Inc.View Profile |
BOPA (The British On...View Profile |
Medneon (Acquired by...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2000 | 1996 | 2018 |
|
Company Size
|
— | 51-200 | 51-200 | 11-50 |
|
City
|
Cambridge, MA | Dartmouth, Nova Scotia | Cupertino, CA | |
|
Country
|
United States | Canada | United States | |
|
Skills & Keywords
Comparing with main company
|
13 Total Skills
Biopharmaceutical
Targeted Therapy
Cancer Treatment
Gene Therapy
Immunotherapy
Oncology
Biotechnology Research
RAS
Pan-RAS
Target Therapy
Bladder Cancer
Cancer
immunotherapy
|
7 Total
7 Unique
Unique Skills:
bladder cancer
breast cancer
DLBCL
DPX Platform
Immuno-Oncology
Ovarian Cancer
+1
|
4 Total
4 Unique
Unique Skills:
Pharmacist
Pharmacy
Treatment
UK
|
17 Total
17 Unique
Unique Skills:
Artificial Intelligence
Breast Cancer
Clinical Insights
Data Science
DNA
Genetic Insights
+11
|
Other organizations in the same industry
This company is also known as